Citation Impact
Citing Papers
Evolution of the Cancer Stem Cell Model
2014 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Cyclooxygenase-Deficient Pancreatic Cancer Cells Use Exogenous Sources of Prostaglandins
2010
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Pancreatic cancer
2004 Standout
Antimitotic activity of methoxyconidiol, a meroterpene isolated from an ascidian
2007
From traditional Chinese medicine to rational cancer therapy
2007 Standout
p63 expression correlates with sensitivity to the Eg5 inhibitor AZD4877 in bladder cancer cells
2012
Apoptosis and autophagy: Regulation of caspase‐9 by phosphorylation
2009
Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis
2016 Standout
Marine natural products
1990 Standout
Taxanes, microtubules and chemoresistant breast cancer
2007
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Omics-based nanomedicine: The future of personalized oncology
2013
DNA methylation: roles in mammalian development
2013 Standout
Stuck in Division or Passing through
2004
Pyroptosis: mechanisms and diseases
2021 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs
2008
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review
2016
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
2007
Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death
2015
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Pyroptosis: A new frontier in cancer
2019 Standout
The CDK inhibitors in cancer research and therapy
2011
Natural compounds for cancer treatment and prevention
2009 Standout
Cervical cancer
2019 Standout
Mitochondria and cell death: outer membrane permeabilization and beyond
2010 Standout
Pancreatic cancer
2011 Standout
The spindle-assembly checkpoint in space and time
2007 Standout
Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
2009
Oxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant Transformation
2015
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells
2020
Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues
2010
Works of Tamotsu Sudo being referenced
Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer.
2007
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
2009
Inhibition of Cell Death and Induction of G2 Arrest Accumulation in Human Ovarian Clear Cells by HNF-1β Transcription Factor
2014
Germ cell specific protein VASA is over-expressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint
2008
Molecular-targeted therapies for ovarian cancer: prospects for the future
2012
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs
2006
Type II Versus Type III Fertility-Sparing Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer
2012
Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint
2004
Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines.
2009